IBIO, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
IBIO, INC. (IBIO) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $582.00 thousand as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-08-28
- 2026-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $582.00K.
- 2025-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $903.00K.
- 2024-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $869.00K.
- 2023-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $883.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2026-06-30 | $582.00K 10-K · filed 2026-08-28 |
| 2025-06-30 | $903.00K 10-K · filed 2026-08-28 |
| 2024-06-30 | $869.00K 10-K · filed 2025-09-05 |
| 2023-06-30 | $883.00K 10-K/A · filed 2024-09-24 |
| 2022-06-30 | $1.25M 10-K · filed 2023-09-27 |
| 2021-06-30 | $353.00K 10-K · filed 2022-10-11 |
| 2020-06-30 | $93.00K 10-K · filed 2021-09-28 |
| 2019-06-30 | $2.24M 10-K · filed 2020-10-13 |
| 2018-06-30 | $2.21M 10-K · filed 2019-08-26 |
| 2017-06-30 | $3.07M 10-K · filed 2018-09-18 |
| 2016-06-30 | $726.00K 10-K · filed 2017-09-15 |
| 2015-06-30 | $3.99M 10-K · filed 2016-10-13 |
| 2014-06-30 | $3.63M 10-K · filed 2015-10-13 |
| 2013-06-30 | $3.20M 10-K · filed 2014-09-29 |
| 2012-06-30 | $2.68M 10-K/A · filed 2013-10-04 |
| 2011-06-30 | $1.62M 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |